Cysteine linked nanobody dimers
US-12384835-B2 · Aug 12, 2025 · US
This page is not indexed by search engines while we improve data quality.
Janssen Daniel patents
Janssen Daniel is listed as an inventor on 11 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Janssen Daniel |
| Total patents | 11 |
| First publication | May 18, 2017 |
| Latest publication | Aug 12, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Polypeptides comprising immunoglobulin single variable domains targeting glypican-3 and t cell receptor
US-2024343823-A1 · Oct 17, 2024 · US
Polypeptides comprising immunoglobulin single variable domains targeting glypican-3 and T cell receptor
US-11932702-B2 · Mar 19, 2024 · US
Cysteine linked nanobody dimers
US-2023211006-A1 · Jul 6, 2023 · US
Cysteine linked nanobody dimers
US-11426468-B2 · Aug 30, 2022 · US
Polypeptides comprising immunoglobulin single variable domains targeting glypican-3 and t cell receptor
US-2022213215-A1 · Jul 7, 2022 · US
KV1.3 binding immunoglobulins
US-11149086-B2 · Oct 19, 2021 · US
Nanobody dimers linked via C-terminally engineered cysteins
US-11021544-B2 · Jun 1, 2021 · US
Nanobody dimers linked via c-terminally engineered cysteins
US-2019100599-A1 · Apr 4, 2019 · US
Cysteine linked nanobody dimers
US-2017360955-A1 · Dec 21, 2017 · US
Recent patents
Latest publications not already listed above.
Kv1.3 binding immunoglobulins
US-2017137512-A1 · May 18, 2017 · US
Major assignees
Companies most often associated with this inventor's publications.
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07K2317/569 | 11 |
| C07K2317/31 | 11 |
| C07K16/18 | 9 |
| C07K2317/92 | 9 |
| C07K2317/94 | 9 |